June 2022 Content Release Copied

06/30/20222022 ContentContent releasePhysician, Clinical, Admin, Billing

Clinical Profile Documentation

Problems

Additions

The Problems > Add Details area for Neuroendocrine tumors and Renal cell carcinoma has been updated with applicable documentation points for Germline VHL (von Hippel Lindau) Alteration Status:

Positive, pathogenic or likely pathogenic
Variant of undetermined significance
Negative
Unknown

Updates

This release contains additional TNM values, and Staging selections for Bladder Cancer to align with AJCC 8th Edition conditions. The new content does not affect previous charting documented on existing patients. All previous charting is brought forward during a subsequent visit, just as it did prior to this release.

Staging Type	Tumor Type	Node	Metastasis	Stage
Clinical	T2	N0	cM0	II
Clinical	T3	N0	cM0	IIIA

Charge Capture

The following items are available for documentation in Problems and appear on the Charge Capture Report (CCR). Additional ICD-10 code choices* may display to present the surrounding nodes.

Problem	ICD-10 Code(s)*
Abdominal aortic atherosclerosis (disorder)	I70.0 Atherosclerosis of aorta
Abdominal mass (finding)	R19.00 Intra-abdominal and pelvic swelling, mass and lump unspecified site R19.01 Right upper quadrant abdominal swelling, mass and lump R19.02 Left upper quadrant abdominal swelling, mass and lump R19.03 Right lower quadrant abdominal swelling, mass and lump R19.04 Left lower quadrant abdominal swelling, mass and lumpR19.05 Periumbilic swelling, mass or lump R19.06 Epigastric swelling, mass or lump R19.07 Generalized intra-abdominal and pelvic swelling, mass and lump R19.09 Other intra-abdominal and pelvic swelling, mass and lump
Acquired hydronephrosis due to bladder obstruction (disorder)	N13.39 Other hydronephrosis N32.0 Bladder-neck obstruction
Acquired hydronephrosis due to ureteral obstruction (disorder)	N13.0 Hydronephrosis with ureteropelvic junction obstruction N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified
Acute alcoholic liver disease (disorder)	K70.0 Alcoholic fatty liver K70.10 Alcoholic hepatitis without ascites K70.11 Alcoholic hepatitis with ascites K70.2 Alcoholic fibrosis and sclerosis of liver K70.30 Alcoholic cirrhosis without ascites K70.31 Alcoholic cirrhosis with ascites K70.40 Alcoholic hepatic failure without coma K70.41 Alcoholic hepatic failure with coma K70.9 Alcoholic liver disease, unspecified
Acute kidney failure	N17.0 Acute kidney failure with tubular necrosis N17.1 Acute kidney failure with acute cortical necrosis N17.2 Acute kidney failure with medullary necrosis N17.8 Other acute kidney failure N17.9 Acute kidney failure, unspecified
Acute non-ST segment elevation myocardial infarction (disorder)	I21.4 Non-ST elevation (NSTEMI) myocardial infarction
Acute pancreatitis (disorder)	K85.90 Acute pancreatitis without necrosis or infection, unspecified K85.91 Acute pancreatitis with uninfected necrosis, unspecified K85.92 Acute pancreatitis with infected necrosis, unspecified
Acute respiratory failure (disorder)	J96.00 Acute respiratory failure, unspecified whether with hypoxia or hypercapnia J96.01 Acute respiratory failure with hypoxia J96.02 Acute respiratory failure with hypercapnia
Alcohol-induced acute pancreatitis (disorder)	K85.20 Alcohol induced acute pancreatitis without necrosis or infection K85.21 Alcohol induced acute pancreatitis with uninfected necrosis K85.22 Alcohol induced acute pancreatitis with infected necrosis
Alcoholic liver damage (disorder)	K70.0 Alcoholic fatty liver K70.10 Alcoholic hepatitis without ascites K70.11 Alcoholic hepatitis with ascites K70.2 Alcoholic fibrosis and sclerosis of liver K70.30 Alcoholic cirrhosis of liver without ascites K70.31 Alcoholic cirrhosis of liver with ascites K70.40 Alcoholic hepatic failure without coma K70.41 Alcoholic hepatic failure with coma K70.9 Alcoholic liver disease, unspecified
Already on aspirin	Z79.82 Long term (current) use of aspirin
Aneurysm (disorder)	I72.0 Aneurysm of carotid artery I72.1 Aneurysm of artery of upper extremity I72.2 Aneurysm of renal artery I72.3 Aneurysm of iliac artery I72.4 Aneurysm of artery of lower extremity I72.5 Aneurysm of other precerebral arteries I72.6 Aneurysm of vertebral artery I72.8 Aneurysm of other specified arteries I72.9 Aneurysm of unspecified site
Anterior abdominal wall mass (finding)	R19.00 Intra-abdominal and pelvic swelling, mass and lump unspecified site R19.01 Right upper quadrant abdominal swelling, mass and lump R19.02 Left upper quadrant abdominal swelling, mass and lump R19.03 Right lower quadrant abdominal swelling, mass and lump R19.04 Left lower quadrant abdominal swelling, mass and lump R19.05 Periumbilic swelling, mass or lump R19.06 Epigastric swelling, mass or lump R19.07 Generalized intra-abdominal and pelvic swelling, mass and lump R19.09 Other intra-abdominal and pelvic swelling, mass and lump
Anticoagulant therapy (procedure)	Z79.01 Long term (current) use of anticoagulants
Aortocoronary bypass graft present (finding)	Z95.1 Presence of aortocoronary bypass graft
Apoplectic pancreatitis (disorder)	K85.90 Acute pancreatitis without necrosis or infection, unspecified K85.91 Acute pancreatitis with uninfected necrosis, unspecified K85.92 Acute pancreatitis with infected necrosis, unspecified
Arteriosclerotic vascular disease	I25.10 Atherosclerotic heart disease of native coronary artery without angina pectoris I25.110 Atherosclerotic heart disease of native coronary artery with unstable angina pectoris I25.111 Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm I25.118 Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris I25.119 Atherosclerotic heart disease of native coronary artery with unspecified angina pectoris I70.90 Unspecified atherosclerosis I70.91 Generalized atherosclerosis
Aspirin therapy finding (finding)	Z79.82 Long term (current) use of aspirin
Atherosclerosis of aorta (disorder)	I70.0 Atherosclerosis of aorta
Atherosclerosis of arteries of the extremities (disorder)	I70.201 Unspecified atherosclerosis of native arteries of extremities, right leg I70.202 Unspecified atherosclerosis of native arteries of extremities, left leg I70.203 Unspecified atherosclerosis of native arteries of extremities, bilateral legs I70.208 Unspecified atherosclerosis of native arteries of extremities, other extremity I70.209 Unspecified atherosclerosis of native arteries of extremities, unspecified extremity I70.301 Unspecified atherosclerosis of unspecified type of bypass graft(s) of the extremities, right leg I70.302 Unspecified atherosclerosis of unspecified type of bypass graft(s) of the extremities, left leg I70.303 Unspecified atherosclerosis of unspecified type of bypass graft(s) of the extremities, bilateral legs I70.308 Unspecified atherosclerosis of unspecified type of bypass graft(s) of the extremities, other extremity I70.309 Unspecified atherosclerosis of unspecified type of bypass graft(s) of the extremities, unspecified extremity I70.401 Unspecified atherosclerosis of autologous vein bypass graft(s) of the extremities, right leg I70.402 Unspecified atherosclerosis of autologous vein bypass graft(s) of the extremities, left leg I70.403 Unspecified atherosclerosis of autologous vein bypass graft(s) of the extremities, bilateral legs I70.408 Unspecified atherosclerosis of autologous vein bypass graft(s) of the extremities, other extremity I70.409 Unspecified atherosclerosis of autologous vein bypass graft(s) of the extremities, unspecified extremity I70.501 Unspecified atherosclerosis of nonautologous biological bypass graft(s) of the extremities, right leg I70.502 Unspecified atherosclerosis of nonautologous biological bypass graft(s) of the extremities, left leg I70.503 Unspecified atherosclerosis of nonautologous biological bypass graft(s) of the extremities, bilateral legs I70.508 Unspecified atherosclerosis of nonautologous biological bypass graft(s) of the extremities, other extremity I70.509 Unspecified atherosclerosis of nonautologous biological bypass graft(s) of the extremities, unspecified extremity I70.601 Unspecified atherosclerosis of nonbiological bypass graft(s) of the extremities, right leg I70.602 Unspecified atherosclerosis of nonbiological bypass graft(s) of the extremities, left leg I70.603 Unspecified atherosclerosis of nonbiological bypass graft(s) of the extremities, bilateral legs I70.608 Unspecified atherosclerosis of nonbiological bypass graft(s) of the extremities, other extremity I70.609 Unspecified atherosclerosis of nonbiological bypass graft(s) of the extremities, unspecified extremity
Atherosclerosis of artery (disorder)	I70.8 Atherosclerosis of other arteries I70.90 Unspecified atherosclerosis I70.91 Generalized atherosclerosis I70.92 Chronic total occlusion of artery of the extremities
Atherosclerosis of coronary artery (disorder)	I25.10 Atherosclerotic heart disease of native coronary artery without angina pectoris I25.110 Atherosclerotic heart disease of native coronary artery with unstable angina pectoris I25.111 Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm I25.118 Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris I25.119 Atherosclerotic heart disease of native coronary artery with unspecified angina pectoris I25.810 Atherosclerosis of coronary artery bypass graft(s) without angina pectoris I25.811 Atherosclerosis of native coronary artery of transplanted heart without angina pectoris I25.812 Atherosclerosis of bypass graft of coronary artery of transplanted heart without angina pectoris I25.82 Chronic total occlusion of coronary artery I25.83 Coronary atherosclerosis due to lipid rich plaque I25.84 Coronary atherosclerosis due to calcified coronary lesion I25.89 Other forms of chronic ischemic heart disease
Atherosclerosis of native arteries of the extremities (disorder)	I70.201 Unspecified atherosclerosis of native arteries of extremities, right leg I70.202 Unspecified atherosclerosis of native arteries of extremities, left leg I70.203 Unspecified atherosclerosis of native arteries of extremities, bilateral legs I70.208 Unspecified atherosclerosis of native arteries of extremities, other extremity I70.209 Unspecified atherosclerosis of native arteries of extremities, unspecified extremity
Attends hormone replacement monitoring (finding)	Z51.81 Encounter for therapeutic drug level monitoring Z79.890 Hormone replacement therapy
Benign neoplasm of uterus	D26.1 Other benign neoplasm of corpus uteri D26.7 Other benign neoplasm of other parts of uterus D26.9 Other benign neoplasm of uterus, unspecified
Biventricular automatic implantable cardioverter defibrillator present (finding)	Z95.810 Presence of automatic (implantable) cardiac defibrillator
Biventricular cardiac pacemaker present (finding)	Z95.0 Presence of cardiac pacemaker
Bronchitis (disorder)	J40 Bronchitis, not specified as acute or chronic J41.0 Simple chronic bronchitis J41.1 Mucopurulent chronic bronchitis 41.8 Mixed simple and mucopurulent chronic bronchitis J42 Unspecified chronic bronchitis
Cardiac arrest (disorder)	I46.2 Cardiac arrest due to underlying cardiac condition I46.8 Cardiac arrest due to other underlying condition I46.9 Cardiac arrest, cause unspecified
Cardiac arrhythmia (disorder)	I47.0 Re-entry ventricular arrhythmia I47.1 Supraventricular tachycardia I47.2 Ventricular tachycardia I47.9 Paroxysmal tachycardia, unspecified I48.0 Paroxysmal atrial fibrillation I48.11 Longstanding persistent atrial fibrillation I48.19 Other persistent atrial fibrillation I48.20 Chronic atrial fibrillation, unspecified I48.21 Permanent atrial fibrillation I48.3 Typical atrial flutter I48.4 Atypical atrial flutter I48.91 Unspecified atrial fibrillation I48.92 Unspecified atrial flutter I49.01 Ventricular fibrillation I49.02 Ventricular flutter I49.1 Atrial premature depolarization I49.2 Junctional premature depolarization I49.3 Ventricular premature depolarization I49.40 Unspecified premature depolarization I49.49 Other premature depolarization I49.5 Sick sinus syndrome I49.8 Other specified cardiac arrhythmias I49.9 Cardiac arrhythmia, unspecified
Cardiac defibrillator in situ (finding)	Z95.810 Presence of automatic (implantable) cardiac defibrillator
Cardiac pacemaker active on electrocardiogram (finding)	Z95.0 Presence of cardiac pacemaker
Cardiac pacemaker in situ	Z95.0 Presence of cardiac pacemaker
Cardiac pacemaker replaced (situation)	Z95.0 Presence of cardiac pacemaker
Cerebral atherosclerosis (disorder)	I67.2 Cerebral atherosclerosis
Cerebral infarction (disorder)	I63.00 Cerebral infarction due to thrombosis of unspecified precerebral artery I63.09 Cerebral infarction due to thrombosis of other precerebral artery I63.10 Cerebral infarction due to embolism of unspecified precerebral artery I63.20 Cerebral infarction due to unspecified occlusion or stenosis of unspecified precerebral arteries I63.211 Cerebral infarction due to unspecified occlusion or stenosis of right vertebral artery I63.212 Cerebral infarction due to unspecified occlusion or stenosis of left vertebral artery I63.213 Cerebral infarction due to unspecified occlusion or stenosis of bilateral vertebral arteries I63.219 Cerebral infarction due to unspecified occlusion or stenosis of unspecified vertebral artery I63.22 Cerebral infarction due to unspecified occlusion or stenosis of basilar artery I63.231 Cerebral infarction due to unspecified occlusion or stenosis of right carotid arteries I63.232 Cerebral infarction due to unspecified occlusion or stenosis of left carotid arteries I63.233 Cerebral infarction due to unspecified occlusion or stenosis of bilateral carotid arteries I63.239 Cerebral infarction due to unspecified occlusion or stenosis of unspecified carotid artery I63.29 Cerebral infarction due to unspecified occlusion or stenosis of other precerebral arteries I63.30 Cerebral infarction due to thrombosis of unspecified cerebral artery I63.311 Cerebral infarction due to thrombosis of right middle cerebral artery I63.312 Cerebral infarction due to thrombosis of left middle cerebral artery I63.313 Cerebral infarction due to thrombosis of bilateral middle cerebral arteries I63.319 Cerebral infarction due to thrombosis of unspecified middle cerebral artery I63.40 Cerebral infarction due to embolism of unspecified cerebral artery I63.411 Cerebral infarction due to embolism of right middle cerebral artery I63.412 Cerebral infarction due to embolism of left middle cerebral artery I63.413 Cerebral infarction due to embolism of bilateral middle cerebral arteries I63.419 Cerebral infarction due to embolism of unspecified middle cerebral artery I63.50 Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebral artery I63.511 Cerebral infarction due to unspecified occlusion or stenosis of right middle cerebral artery I63.512 Cerebral infarction due to unspecified occlusion or stenosis of left middle cerebral artery I63.513 Cerebral infarction due to unspecified occlusion or stenosis of bilateral middle cerebral arteries I63.519 Cerebral infarction due to unspecified occlusion or stenosis of unspecified middle cerebral artery I63.521 Cerebral infarction due to unspecified occlusion or stenosis of right anterior cerebral artery I63.522 Cerebral infarction due to unspecified occlusion or stenosis of left anterior cerebral artery I63.523 Cerebral infarction due to unspecified occlusion or stenosis of bilateral anterior cerebral arteries I63.529 Cerebral infarction due to unspecified occlusion or stenosis of unspecified anterior cerebral artery I63.531 Cerebral infarction due to unspecified occlusion or stenosis of right posterior cerebral artery I63.532 Cerebral infarction due to unspecified occlusion or stenosis of left posterior cerebral artery I63.533 Cerebral infarction due to unspecified occlusion or stenosis of bilateral posterior cerebral arteries I63.539 Cerebral infarction due to unspecified occlusion or stenosis of unspecified posterior cerebral artery I63.6 Cerebral infarction due to cerebral venous thrombosis, nonpyogenic I63.81 Other cerebral infarction due to occlusion or stenosis of small artery I63.89 Other cerebral infarction I63.9 Cerebral infarction, unspecified
Chronic liver disease (disorder)	K76.9 Liver disease, unspecified
Chronic obstructive lung disease (disorder)	J44.0 Chronic obstructive pulmonary disease with (acute) lower respiratory infection J44.1 Chronic obstructive pulmonary disease with (acute) exacerbation J44.9 Chronic obstructive pulmonary disease, unspecified
Chronic pancreatitis (disorder)	K86.0 Alcohol-induced chronic pancreatitis K86.1 Other chronic pancreatitis
Chronic renal disease	N18.1 – Chronic kidney disease, stage 1 N18.2 – Chronic kidney disease, stage 2 (mild) N18.30 – Chronic kidney disease, stage 3 unspecified N18.31 – Chronic kidney disease, stage 3a N18.32 – Chronic kidney disease, stage 3b N18.4 – Chronic kidney disease, stage 4 (severe) N18.5 – Chronic kidney disease, stage 5 N18.6 – End stage renal disease N18.9 – Chronic kidney disease, unspecified
Chronic respiratory failure (disorder)	J96.10 Chronic respiratory failure, unspecified whether with hypoxia or hypercapnia J96.11 Chronic respiratory failure with hypoxia J96.12 Chronic respiratory failure with hypercapnia
Coma (disorder)	R40.20 Unspecified coma
Combination internal cardiac defibrillator and pacemaker in situ (finding)	Z95.810 Presence of automatic (implantable) cardiac defibrillator
Coronary arteriosclerosis (disorder)	I25.10 Atherosclerotic heart disease of native coronary artery without angina pectoris I25.110 Atherosclerotic heart disease of native coronary artery with unstable angina pectoris I25.111 Atherosclerotic heart disease of native coronary artery with documented spasm I25.118 Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris I25.119 Atherosclerotic heart disease of native coronary artery with unspecified angina pectoris
Coronary artery bypass graft stent present (finding)	Z95.1 Presence of aortocoronary bypass graft
Crohn’s disease (disorder)	K50.90 Crohn’s disease, unspecified, without complications K50.911 Crohn’s disease, unspecified, with rectal bleeding K50.912 Crohn’s disease, unspecified, with intestinal obstruction K50.913 Crohn’s disease, unspecified, with fistula K50.914 Crohn’s disease, unspecified, with abscess K50.918 Crohn’s disease, unspecified, with other complication K50.919 Crohn’s disease, unspecified, with unspecified complications
Crohn’s disease of intestine (disorder)	K50.90 Crohn’s disease, unspecified, without complications K50.911 Crohn’s disease, unspecified, with rectal bleeding K50.912 Crohn’s disease, unspecified, with intestinal obstruction K50.913 Crohn’s disease, unspecified, with fistula K50.914 Crohn’s disease, unspecified, with abscess K50.918 Crohn’s disease, unspecified, with other complication K50.919 Crohn’s disease, unspecified, with unspecified complications
Crohn’s disease of large bowel (disorder)	K50.10 Crohn’s disease of large intestine without complications K50.111 Crohn’s disease of large intestine with rectal bleeding K50.112 Crohn’s disease of large intestine with intestinal obstruction K50.113 Crohn’s disease of large intestine with fistula K50.114 Crohn’s disease of large intestine with abscess K50.118 Crohn’s disease of large intestine with other complication K50.119 Crohn’s disease of large intestine with unspecified complications
Crohn’s disease of small and large intestines (disorder)	K50.80 Crohn’s disease of both small and large intestine without complications K50.811 Crohn’s disease of both small and large intestine with rectal bleeding K50.812 Crohn’s disease of both small and large intestine with intestinal obstruction K50.813 Crohn’s disease of both small and large intestine with fistula K50.814 Crohn’s disease of both small and large intestine with abscess K50.818 Crohn’s disease of both small and large intestine with other complication K50.819 Crohn’s disease of both small and large intestine with unspecified complications
Crohn’s disease of small intestine (disorder)	K50.00 Crohn’s disease of small intestine without complications K50.011 Crohn’s disease of small intestine with rectal bleeding K50.012 Crohn’s disease of small intestine with intestinal obstruction K50.013 Crohn’s disease of small intestine with fistula K50.014 Crohn’s disease of small intestine with abscess K50.018 Crohn’s disease of small intestine with other complication K50.019 Crohn’s disease of small intestine with unspecified complications
Device in situ (finding)	Z97.8 Presence of other specified devices
Diabetic monitoring – injection sites	E10.9 Type 1 diabetes mellitus without complications T80.90XA Unspecified complication following infusion and therapeutic injection, initial encounter T80.90XD Unspecified complication following infusion and therapeutic injection, subsequent encounter T80.90XS Unspecified complication following infusion and therapeutic injection, sequela Z79.4 Long term (current) use of insulin
Diabetic on insulin (finding)	E10.9 Type 1 diabetes mellitus without complications E11.9 Type 2 diabetes mellitus without complications Z79.4 Long term (current) use of insulin
Diabetic on oral treatment (finding)	E11.9 Type 2 diabetes mellitus without complications Z79.84 Long term (current) use of oral hypoglycemic drugs
Disease (disorder)	R69 Illness, unspecified R99 Ill-defined and unknown cause of mortality
Disorder of liver (disorder)	K70.0 Alcoholic fatty liver K70.10 Alcoholic hepatitis without ascites K70.11 Alcoholic hepatitis with ascites K70.2 Alcoholic fibrosis and sclerosis of liver K70.30 Alcoholic cirrhosis of liver without ascites K70.40 Alcoholic hepatic failure without coma K70.9 Alcoholic liver disease, unspecified K71.0 Toxic liver disease with cholestasis K71.10 Toxic liver disease with hepatic necrosis, without coma K71.2 Toxic liver disease with acute hepatitis K71.3 Toxic liver disease with chronic persistent hepatitis K71.4 Toxic liver disease with chronic lobular hepatitis K71.50 Toxic liver disease with chronic active hepatitis without ascites K71.51 Toxic liver disease with chronic active hepatitis with ascites K71.6 Toxic liver disease with hepatitis, not elsewhere classified K71.7 Toxic liver disease with fibrosis and cirrhosis of liver K71.9 Toxic liver disease, unspecified K72.00 Acute and subacute hepatic failure without coma K72.10 Chronic hepatic failure without coma K72.90 Hepatic failure, unspecified without coma K72.91 Hepatic failure, unspecified with coma K73.0 Chronic persistent hepatitis, not elsewhere classified K73.1 Chronic lobular hepatitis, not elsewhere classified K73.2 Chronic active hepatitis, not elsewhere classified K73.8 Other chronic hepatitis, not elsewhere classified K73.9 Chronic hepatitis, unspecified K74.00 Hepatic fibrosis, unspecified K74.01 Hepatic fibrosis, early fibrosis K74.02 Hepatic fibrosis, advanced fibrosis K74.1 Hepatic sclerosis K74.2 Hepatic fibrosis with hepatic sclerosis K74.3 Primary biliary cirrhosis K74.4 Secondary biliary cirrhosis K74.5 Biliary cirrhosis, unspecified K74.60 Unspecified cirrhosis of liver K74.69 Other cirrhosis of liver K75.0 Abscess of liver K75.1 Phlebitis of portal vein K75.2 Nonspecific reactive hepatitis K75.3 Granulomatous hepatitis, not elsewhere classified K75.4 Autoimmune hepatitis K75.81 Nonalcoholic steatohepatitis (NASH) K75.89 Other specified inflammatory liver diseases K75.9 Inflammatory liver disease, unspecified K76.0 Fatty (change of) liver, not elsewhere classified K76.1 Chronic passive congestion of liver K76.2 Central hemorrhagic necrosis of liver K76.3 Infarction of liver K76.4 Peliosis hepatis K76.5 Hepatic veno-occlusive disease K76.6 Portal hypertension K76.7 Hepatorenal syndrome K76.81 Hepatopulmonary syndrome K76.89 Other specified diseases of liver K76.9 Liver disease, unspecified K77 Liver disorders in diseases classified elsewhere
Drug-induced acute pancreatitis (disorder)	K85.30 Drug induced acute pancreatitis without necrosis or infection K85.31 Drug induced acute pancreatitis with uninfected necrosis K85.32 Drug induced acute pancreatitis with infected necrosis
Endometriosis (disorder)	N80.0 Endometriosis of uterus N80.1 Endometriosis of ovary N80.2 Endometriosis of fallopian tube N80.3 Endometriosis of pelvic peritoneum N80.4 Endometriosis of rectovaginal septum and vagina N80.5 Endometriosis of intestine N80.6 Endometriosis in cutaneous scar N80.8 Other endometriosis N80.9 Endometriosis, unspecified
Heart Failure	I50.1 Left ventricular failure, unspecified I50.20 Unspecified systolic (congestive) heart failure I50.21 Acute systolic (congestive) heart failure I50.22 Chronic systolic (congestive) heart failure I50.23 Acute on chronic systolic (congestive) heart failure I50.30 Unspecified diastolic (congestive) heart failure I50.31 Acute diastolic (congestive) heart failure I50.32 Chronic diastolic (congestive) heart failure I50.33 Acute on chronic diastolic (congestive) heart failure I50.40 Unspecified combined systolic (congestive) and diastolic (congestive) heart failure I50.41 Acute combined systolic (congestive) and diastolic (congestive) heart failure I50.42 Chronic combined systolic (congestive) and diastolic (congestive) heart failure I50.43 Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure I50.810 Right heart failure, unspecified I50.811 Acute right heart failure I50.812 Chronic right heart failure I50.813 Acute on chronic right heart failure I50.814 Right heart failure due to left heart failure I50.82 Biventricular heart failure I50.83 High output heart failure I50.84 End stage heart failure I50.89 Other heart failure I50.9 Heart failure, unspecified
History of artery embolism (situation)	Z86.711 Personal history of pulmonary embolism Z86.718 Personal history of other venous thrombosis and embolism
History of aortic valve replacement	Z95.2 Presence of prosthetic heart valve Z95.3 Presence of xenogenic heart valve Z95.4 Presence of other heart-valve replacement
History of artificial heart (situation)	Z95.812 Presence of fully implantable artificial heart
History of artificial heart valve (situation)	Z95.2 Presence of prosthetic heart valve Z95.3 Presence of xenogenic heart valve Z95.4 Presence of other heart-valve replacement
History of being a tissue or organ recipient (situation)	Z94.9 Transplanted organ and tissue status, unspecified
History of cardiac pacemaker in situ (situation)	Z95.0 Presence of cardiac pacemaker
History of combination internal cardiac defibrillator and pacemaker (situation)	Z95.810 Presence of automatic (implantable) cardiac defibrillator
History of Crohns disease (situation)	Z87.19 Personal history of other diseases of the digestive system
History of heart valve recipient (situation)	Z95.2 Presence of prosthetic heart valve
History of liver disease (situation)	Z87.19 Personal history of other diseases of the digestive system
History of mitral valve replacement	Z95.2 Presence of prosthetic heart valve Z95.3 Presence of xenogenic heart valve Z95.4 Presence of other heart-valve replacement
History of pacemaker in situ (situation)	Z95.0 Presence of cardiac pacemaker
History of pancreatitis (situation)	Z87.19 Personal history of other diseases of the digestive system
History of porcine aortic valve replacement (situation)	Z95.3 Presence of xenogenic heart valve
History of porcine heart valve replacement (situation)	Z95.3 Presence of xenogenic heart valve
Hormone replacement monitoring check done (finding)	Z51.81 Encounter for therapeutic drug level monitoring Z79.890 Hormone replacement therapy
Hormone replacement monitoring status (finding)	Z51.81 Encounter for therapeutic drug level monitoring
Hormone replacement therapy bleed pattern – abnormal (finding)	R79.1 Abnormal coagulation profile Z79.890 Hormone replacement therapy
Hormone replacement therapy bleed pattern – no bleeding (finding)	Z79.890 Hormone replacement therapy
Hormone replacement therapy bleed pattern – not relevant (finding)	Z79.890 Hormone replacement therapy
Hormonal replacement therapy: combined estrogen/progestogen (finding)	Z79.890 Hormone replacement therapy
Hormone replacement therapy started (situation)	Z79.890 Hormone replacement therapy
Hormone replacement therapy side effects (finding)	T38.5X5A Adverse effect of other estrogens and progestogens, initial encounter T38.5X5D Adverse effect of other estrogens and progestogens, subsequent encounter T38.5X5S Adverse effect of other estrogens and progestogens, sequela Z79.890 Hormone replacement therapy
Hormonal replacement therapy: unopposed estrogen (finding)	Z79.890 Hormone replacement therapy
Hydronephrosis (disorder)	N13.0 Hydronephrosis with ureteropelvic junction obstruction N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified N13.2 Hydronephrosis with renal and ureteral calculous obstruction N13.30 Unspecified hydronephrosis
Idiopathic acute pancreatitis (disorder)	K85.00 Idiopathic acute pancreatitis without necrosis or infection K85.01 Idiopathic acute pancreatitis with uninfected necrosis K85.02 Idiopathic acute pancreatitis with infected necrosis
Inflammatory disease of liver (disorder)	K75.0 Abscess of liver K75.1 Phlebitis of portal vein K75.2 Nonspecific reactive hepatitis K75.3 Granulomatous hepatitis, not elsewhere classified K75.4 Autoimmune hepatitis K75.81 Nonalcoholic steatohepatitis (NASH) K75.89 Other specified inflammatory liver diseases K75.9 Inflammatory liver disease, unspecified
Inhaled steroids used daily (situation)	Z79.51 Long term (current) use of inhaled steroids
Inhaled steroids use (finding)	Z79.51 Long term (current) use of inhaled steroids
Inhaler technique – good (finding)	Z79.51 Long term (current) use of inhaled steroids Z79.899 Other long term (current) drug therapy
Insulin dependent diabetes mellitus type IB (disorder)	E10.9 Type 1 diabetes mellitus without complications Z79.4 Long term (current) use of insulin
Iron deficiency anemia (disorder)	D50.0 – Iron deficiency anemia secondary to blood loss (chronic) D50.1 – Sideropenic dysphagia D50.8 – Other iron deficiency anemias D50.9 – Iron deficiency anemia, unspecified
Left cardiac ventricle to aorta assist device in situ (finding)	Z95.811 Presence of heart assist device
Leiomyosarcoma of connective tissue (disorder)	C49.3 Malignant neoplasm of connective and soft tissue of thorax C49.4 Malignant neoplasm of connective and soft tissue of abdomen C49.5 Malignant neoplasm of connective and soft tissue of pelvis C49.6 Malignant neoplasm of connective and soft tissue of trunk, unspecified C49.8 Malignant neoplasm of overlapping sites of connective and soft tissue C49.9 Malignant neoplasm of connective and soft tissue, unspecified
Liposarcoma of connective tissue (disorder)	C49.3 Malignant neoplasm of connective and soft tissue of thorax C49.4 Malignant neoplasm of connective and soft tissue of abdomen C49.5 Malignant neoplasm of connective and soft tissue of pelvis C49.6 Malignant neoplasm of connective and soft tissue of trunk, unspecified C49.8 Malignant neoplasm of overlapping sites of connective and soft tissue C49.9 Malignant neoplasm of connective and soft tissue, unspecified
Long term current use of abatacept	Z79.899 Other long term (current) drug therapy
Long-term current use of acitretin (situation)	Z79.899 Other long term (current) drug therapy
Long term current use of adalimumab therapy (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of ambrisentan (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of amiodarone (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of anakinra (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of antibiotics for prevention of recurrent infection (situation)	Z79.2 Long term (current) use of antibiotics
Long-term current use of antidepressant medication (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of antipsychotic medication (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of antithrombotic (situation)	Z79.02 Long term (current) use of antithrombotics/antiplatelets
Long-term current use of antiviral agent (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of anxiolytic medication	Z79.899 Other long term (current) drug therapy
Long-term current use of apremilast (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of auranofin (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of azathioprine (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of belimumab (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of bisphosphonates (situation)	Z79.83 Long term (current) use of bisphosphonates
Long-term current use of certolizumab pegol (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of clozapine (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of cyclophosphamide (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of cyclosporine (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of diuretic (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of deferasirox (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of drug therapy	Z79.899 Other long term (current) drug therapy
Long term current use of drug therapy for attention deficit hyperactivity disorder (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of erythropoiesis stimulating therapy (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of etanercept (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of felbamate (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of filgrastim (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of golimumab (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of growth hormone (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of high dose acetaminophen (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of hormonal contraceptive (situation)	Z79.3 Long term (current) use of hormonal contraceptives
Long-term current use of hydroxychloroquine (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of inhaled steroid (situation)	Z79.51 Long term (current) use of inhaled steroids
Long-term current use of intravenous immune globulin (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of isotretinoin (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of leflunomide (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of lenalidomide (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of leuprolide	Z79.818 Long term (current) use of other agents affecting estrogen receptors and estrogen levels
Long-term current use of levothyroxine (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of lithium (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of medicinal gold (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of mercaptopurine (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of mycophenolate (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of natalizumab (situation)	Z79.899 Other long term (current) drug therapy
Long term current use of non- steroidal anti-inflammatory drug (situation)	Z79.1 Long term (current) use of non-steroidal anti- inflammatories (NSAID)
Long-term current use of opiate analgesic drug (situation)	Z79.891 Long term (current) use of opiate analgesic
Long-term current use of oral hypoglycemic medication	Z79.84 Long term (current) use of oral hypoglycemic drugs
Long-term current use of postmenopausal hormone replacement therapy (situation)	Z79.890 Hormone replacement therapy
Long-term current use of proton pump inhibitor therapy (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of retinoid (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of rituximab (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of secukinumab (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of sirolimus (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of sulfasalazine	Z79.2 Long term (current) use of antibiotics
Long-term current use of systemic steroid (situation)	Z79.52 Long term (current) use of systemic steroids
Long-term current use of tacrolimus (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of testosterone cypionate (situation)	Z79.52 Long term (current) use of systemic steroids
Long-term current use of thyroid hormone replacement therapy (situation)	Z79.890 Hormone replacement therapy
Long-term current use of tocilizumab (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of tofacitinib (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of ustekinumab (situation)	Z79.899 Other long term (current) drug therapy
Long-term current use of vedolizumab (situation)	Z79.899 Other long term (current) drug therapy
Long term methotrexate user (finding)	Z79.899 Other long term (current) drug therapy
Long term systemic steroid user	Z79.52 Long term (current) use of systemic steroids
Long term use of insulin	Z79.4 Long term (current) use of insulin
Lung mass (finding)	D38.1 Neoplasm of uncertain behavior of trachea, bronchus and lung R91.8 Other nonspecific abnormal finding of lung field
Male to female transsexual person on hormone therapy (finding)	F64.0 Transsexualism Z79.890 Hormone replacement therapy
Malignant epithelial neoplasm of peritoneum (disorder)	C48.0 Malignant neoplasm of retroperitoneum C48.1 Malignant neoplasm of specified parts of peritoneum C48.2 Malignant neoplasm of peritoneum, unspecified C48.8 Malignant neoplasm of overlapping sites of retroperitoneum and peritoneum
Mass of pancreas (finding)	C49.A9 – Gastrointestinal stromal tumor of other sites D37.8 – Neoplasm of uncertain behavior of other specified digestive organs K86.9 – Disease of pancreas, unspecified
Neoplasm of abdomen (disorder)	C76.2 Malignant neoplasm of abdomen D49.89 Neoplasm of unspecified behavior of other specified sites
Malignant neoplasm of connective and soft tissue of abdominal wall (disorder)	C49.4 Malignant neoplasm of connective and soft tissue of abdomen
Malignant neoplasm of connective tissue (disorder)	C49.9 Malignant neoplasm of connective and soft tissue, unspecified
Malignant neoplasm of digestive system (disorder)	C26.0 Malignant neoplasm of intestinal tract, part unspecified C26.1 Malignant neoplasm of spleen C26.9 Malignant neoplasm of ill-defined sites within the digestive system
Malignant neoplasm of mesentery (disorder)	C48.0 Malignant neoplasm of retroperitoneum C48.1 Malignant neoplasm of specified parts of peritoneum C48.2 Malignant neoplasm of peritoneum, unspecified C48.8 Malignant neoplasm of overlapping sites of retroperitoneum and peritoneum
Malignant neoplasm of omentum (disorder)	C48.1 Malignant neoplasm of specified parts of peritoneum
Malignant neoplasm of pelvic peritoneum (disorder)	C48.1 Malignant neoplasm of specified parts of peritoneum C48.2 Malignant neoplasm of peritoneum, unspecified
Malignant neoplasm of perinephric tissue (disorder)	C48.0 Malignant neoplasm of retroperitoneum
Malignant neoplasm of retrocecal tissue (disorder)	C48.0 Malignant neoplasm of retroperitoneum
Malignant neoplasm of soft tissue (disorder)	C49.9 Malignant neoplasm of connective and soft tissue, unspecified
Malignant neoplasm of the pouch of Douglas (disorder)	C48.1 Malignant neoplasm of specified parts of peritoneum
Malignant peritoneal local recurrence (disorder)	C48.0 Malignant neoplasm of retroperitoneum C48.1 Malignant neoplasm of specified parts of peritoneum C48.2 Malignant neoplasm of peritoneum, unspecified C48.8 Malignant neoplasm of overlapping sites of retroperitoneum and peritoneum
Malignant pleural effusion	C80.1 Malignant (primary) neoplasm, unspecified J91.0 Malignant pleural effusion J91.8 Pleural effusion in other conditions classified elsewhere
Malignant retroperitoneal tumor (disorder)	C48.0 Malignant neoplasm of retroperitoneum
Malignant tumor of pelvis (disorder)	C76.3 Malignant neoplasm of pelvis
Malignant tumor of peritoneum and retroperitoneum (disorder)	C48.8 Malignant neoplasm of overlapping sites of retroperitoneum and peritoneum
Mass of soft tissue (finding)	M79.81 Nontraumatic hematoma of soft tissue M79.9 Soft tissue disorder, unspecified R22.9 Localized swelling, mass and lump, unspecified
MRSA positive	Z22.322 Carrier or suspected carrier of Methicillin resistant Staphylococcus aureus
Neoplasm of omentum (disorder)	C48.1 Malignant neoplasm of specified parts of peritoneum C48.2 Malignant neoplasm of peritoneum, unspecified D20.1 Benign neoplasm of soft tissue of peritoneum
Neoplasm of pelvis (disorder)	C76.3 Malignant neoplasm of pelvis
Neoplasm of peritoneum (disorder)	C48.1 Malignant neoplasm of specified parts of peritoneum C48.2 Malignant neoplasm of peritoneum, unspecified D20.1 Benign neoplasm of soft tissue of peritoneum
Normally functioning cardiac pacemaker present (finding)	Z95.0 Presence of cardiac pacemaker
Opioid dependence, on agonist therapy (disorder)	F11.20 Opioid dependence, uncomplicated
Pancreatitis (disorder)	K85.90 Acute pancreatitis without necrosis or infection, unspecified K85.91 Acute pancreatitis with uninfected necrosis, unspecified K85.92 Acute pancreatitis with infected necrosis, unspecified
Peripherally inserted central venous catheter in situ (finding)	Z95.828 Presence of other vascular implants and grafts
Peritoneum cancer	C48.0 Malignant neoplasm of retroperitoneum C48.1 Malignant neoplasm of specified parts of peritoneum C48.2 Malignant neoplasm of peritoneum, unspecified C48.8 Malignant neoplasm of overlapping sites of retroperitoneum and peritoneum
PICC (peripherally inserted central catheter) in situ	Z95.828 Presence of other vascular implants and grafts
Permanent cardiac pacemaker (finding)	Z95.0 Presence of cardiac pacemaker
Pleural effusion (disorder)	J90 Pleural effusion, not elsewhere classified
Pleural effusion due to malignant neoplastic disease (disorder)	C80.1 Malignant (primary) neoplasm, unspecified J91.0 Malignant pleural effusion J91.8 Pleural effusion in other conditions classified elsewhere
Pleural effusion due to neoplastic disease (disorder)	C80.1 Malignant (primary) neoplasm, unspecified D49.1 Neoplasm of unspecified behavior of respiratory system D49.9 Neoplasm of unspecified behavior of unspecified site J91.0 Malignant pleural effusion J91.8 Pleural effusion in other conditions classified elsewhere
Pneumonia (disorder)	J18.0 Bronchopneumonia, unspecified organism J18.1 Lobar pneumonia, unspecified organism J18.2 Hypostatic pneumonia, unspecified organism J18.8 Other pneumonia, unspecified organism J18.9 Pneumonia, unspecified organism
Presence of coronary artery stent in patient with coronary artery disease (disorder)	Z95.5 – Presence of coronary angioplasty implant and graft
Presence of inferior vena cava filter	Z95.828 Presence of other vascular implants and grafts
Primary adenocarcinoma of overlapping sites of retroperitoneum, peritoneum and omentum (disorder)	C48.8 Malignant neoplasm of overlapping sites of retroperitoneum and peritoneum
Primary liposarcoma of soft tissue of abdomen (disorder)	C48.2 Malignant neoplasm of peritoneum, unspecified C49.4 Malignant neoplasm of connective and soft tissue of abdomen
Primary liposarcoma of soft tissue of trunk (disorder)	C48.2 Malignant neoplasm of peritoneum, unspecified C49.3 Malignant neoplasm of connective and soft tissue of thorax C49.4 Malignant neoplasm of connective and soft tissue of abdomen C49.5 Malignant neoplasm of connective and soft tissue of pelvis C49.6 Malignant neoplasm of connective and soft tissue of trunk, unspecified
Primary malignant neoplasm of abdomen (disorder)	C76.2 Malignant neoplasm of abdomen
Primary malignant neoplasm of adrenal gland (disorder)	C74.00 Malignant neoplasm of cortex of unspecified adrenal gland C74.01 Malignant neoplasm of cortex of right adrenal gland C74.02 Malignant neoplasm of cortex of left adrenal gland C74.10 Malignant neoplasm of medulla of unspecified adrenal gland C74.11 Malignant neoplasm of medulla of right adrenal gland C74.12 Malignant neoplasm of medulla of left adrenal gland C74.90 Malignant neoplasm of unspecified part of unspecified adrenal gland C74.91 Malignant neoplasm of unspecified part of right adrenal gland
Primary malignant neoplasm of omentum (disorder)	C48.1 Malignant neoplasm of specified parts of peritoneum
Primary malignant neoplasm of parietal peritoneum (disorder)	C48.1 Malignant neoplasm of specified parts of peritoneum
Primary malignant neoplasm of pelvic peritoneum (disorder)	C48.1 Malignant neoplasm of specified parts of peritoneum C48.2 Malignant neoplasm of peritoneum, unspecified
Primary malignant neoplasm of pelvis (disorder)	C76.3 Malignant neoplasm of pelvis
Primary malignant neoplasm of retroperitoneum (disorder)	C48.0 Malignant neoplasm of retroperitoneum
Primary malignant neoplasm of soft tissues (disorder)	C49.9 Malignant neoplasm of connective and soft tissue, unspecified
Primary malignant neoplasm of soft tissues of abdomen (disorder)	C49.4 Malignant neoplasm of connective and soft tissue of abdomen
Respiratory arrest (disorder)	R09.2 Respiratory arrest
Rhythm from artificial pacing (finding)	Z95.0 Presence of cardiac pacemaker
Secondary malignancy of bilateral ovaries	C79.63 Secondary malignant neoplasm of bilateral ovaries
Secondary malignancy of ovary	C79.60 – Secondary malignant neoplasm of unspecified ovary C79.61 – Secondary malignant neoplasm of right ovary C79.62 – Secondary malignant neoplasm of left ovary
Secondary malignant neoplasm of uterus	C79.82 – Secondary malignant neoplasm of genital organs
Secondary malignancy of vagina	C79.82 – Secondary malignant neoplasm of genital organs
Secondary malignant neoplasm of vulva	C79.82 – Secondary malignant neoplasm of genital organs
Stent in right coronary artery present (finding)	Z95.5 Presence of coronary angioplasty implant and graft
Stented coronary artery	Z95.5 Presence of coronary angioplasty implant and graft
Transsexual (finding)	F64.0 Transsexualism
Tuberculosis prophylaxis started (situation)	Z76.89 Persons encountering health services in other specified circumstances
Tumor of peritoneum and retroperitoneum (disorder)	C48.8 Malignant neoplasm of overlapping sites of retroperitoneum and peritoneum
Vulvodynia (disorder)	N94.818 Other vulvodynia N94.819 Vulvodynia, unspecified
Warfarin monitoring (regime/therapy)	Z79.01 Long term (current) use of anticoagulants

Lab, Analytes, and Panels

Additions

Allergy evaluation 8, arid southwest panel
Alpha globin gene deletion or duplication panel
CA 125 (serial monitor) panel
CA 15-3 (serial monitor) panel
CA 19-9 (serial monitor) panel
CA 27-29 (serial monitor) panel
CEA (serial monitor) panel
CMI677-ROS1 FISH panel
Cryptococcus ab, quant panel
Erythrocyte porphyrin (EP), whole blood panel
Erythrocyte porphyrin (EP), whole blood, ug/dL
False ragweed (W4) IGE, class
False ragweed (W4) IGE, kU/L
HPV mRNA E6/E7, post-hysterectomy, vaginal panel
Invitae multi-cancer panel + GALNT12
Invitae multi-cancer panel + GALNT12 results
Invitae schwannomatosis panel
Invitae schwannomatosis panel results

Medications

Additions

AC176 invest Oral
Alymsys (Bevacizumab-maly IV)
AMG 900 invest Oral
ARQ 087 invest Oral
Bevacizumab-maly IV
BT8009 invest IV
CC-122 HCI invest Oral
EC1169 invest IV
KIT D816V digital PCR, high sensitivity panel
Myriad BRACAnalysis CDx panel
Myriad BRACAnalysis pdf
Myriad EndoPredict panel
Myriad EndoPredict pdf
Myriad MyChoice CDx panel
Myriad MyChoice CDx pdf
Myriad MyRisk panel
Myriad MyRisk pdf
Myriad Precise tumor panel
Myriad Precise tumor pdf
Myriad Prolaris panel
Myriad Prolaris pdf
NGS miscellaneous panel
N-Telopeptide, serum panel
N-Telopeptide, serum, nM BCE/L
N-Telopeptide, serum, nM BCE/L
PSA (serial monitor) panel
TSH Ab panel
Venous thrombosis, patients on VKA panel
VTE
VTE Prophylaxis Exception
Emactuzumab invest IV
Futibatinib invest (TAS-120 invest Oral)
IDE397 invest Oral
MEHD7945A invest IV
PEEL-224 invest IV
RO198457 invest IV
SGN-CD70A invest IV

Updates

Medication	Update
Bortezomib (FRESENIUS) IV	Inactivated
Cyclosporine Modified Oral	New Rounding Rule available: 25 mg
Evusheld (Tixagevimab-Cilgavimab IM Dose Pack 150 mg/1.5 mL-150 mg/1.5 mL (EUA))	New default Sig available: 2 dose pk intramuscularly as directed on dose pack; Inject 300 mg tixagevimab and 300 mg cilgavimab (600 mg total dose) as 2 consecutive 3 mL injections
Fentanyl Transdermal Patch 25 mcg/hr	New Sig available: 1 patch transdermal patch every 72 hours; quantity sufficient for 30 days
Ibrutinib Oral	New default dispense and supply available: 28 Tablets for 28 days supply
Kisqali (Ribociclib Oral Dose Pack 200 mg/day)	New default days supply available: 21 days
Kisqali (Ribociclib Oral Dose Pack 400 mg/day)	New default days supply available: 21 days
Kisqali (Ribociclib Oral Dose Pack 600 mg/day)	New default days supply available: 21 days
Kisqali Femara Co-Pack (Ribociclib-Letrozole Oral Dose Pack 600 mg/day-2.5 mg)	New Sig available: Ribociclib-Letrozole 0 tabs orally as directed on dose pack; take 3 – 200 mg/purple tablets (600 mg total) daily for first 21 days of 28-day cycle; take 1 – 2.5 mg/yellow tablet daily for 28 days.; quantity sufficient for 28 days; 28 refills. **Please note, this is an additional Sig Option, please select it as Default at the practice level. Also, the “28 refills” will display as Refills: 3 in Order > Medications.
Kisqali Femara Co-Pack (Ribociclib-Letrozole Oral Dose Pack 400 mg/day-2.5 mg)	New Sig available: Ribociclib-Letrozole 0 tabs orally as directed on dose pack; take 2 – 200 mg/purple tablets (400 mg total) daily for first 21 days of 28-day cycle; take 1 – 2.5 mg/yellow tablet daily for 28 days.; quantity sufficient for 28 days. **Please note, this is an additional Sig Option, please select it as Default at the practice level. Also, the “28 refills” will display as Refills: 3 in Order > Medications.
Kisqali Femara Co-Pack (Ribociclib-Letrozole Oral Dose Pack 200 mg/day-2.5 mg)	New Sig available: Ribociclib-Letrozole 0 tabs orally as directed on dose pack; take 1 – 200 mg/purple tablet daily for first 21 days of 28-day cycle; take 1 – 2.5 mg/yellow tablet daily for 28 days.; quantity sufficient for 28 days. **Please note, this is an additional Sig Option, please select it as Default at the practice level. Also, the “28 refills” will display as Refills: 3 in Order > Medications.
Megestrol Oral Suspension 400 mg/10 mL	New default Sig available: 10 mL orally every day; quantity sufficient for 30 days
Palbociclib Oral	New default Sig available: 125 mg orally daily; administer on days 1 through 21 of a 28-day treatment cycle
Piqray (Alpelisib Oral Dose Pack 200 mg/day)	New default days supply available: 28 days
Piqray (Alpelisib Oral Dose Pack 250 mg/day)	New default days supply available: 28 days
Piqray (Alpelisib Oral Dose Pack 300 mg/day)	New default days supply available: 28 days
Tixagevimab-Cilgavimab IM Dose Pack 150 mg/1.5 mL-150 mg/1.5 mL (EUA)	New default Sig available: 2 dose pk intramuscularly as directed on dose pack; Inject 300 mg tixagevimab and 300 mg cilgavimab (600 mg total dose) as 2 consecutive 3 mL injections

Regimens

The Collaborative Care Committee recently voted to APPROVE the addition of Venous Thromboembolism (VTE) Prophylaxis into Multiple Myeloma regimens. Updates to regimen templates within iKnowMed will be available with this content release and over the next two releases. For more information, please click here.

Additions

Azacitidine D1-7 + Ivosidenib Q28D
Docetaxel + Abiraterone + Prednisone + ADT Q21D (Docetaxel only)
Docetaxel + Abiraterone + Prednisone + ADT Q28D (Abiraterone + Prednisone + Goserelin only)
Docetaxel + Abiraterone + Prednisone + ADT Q28D (Abiraterone + Prednisone + Leuprolide only)
Durvalumab + Gemcitabine D1,8 + Cisplatin D1,8 Q21D
Fluorouracil (Bolus + CIV) D1-2 + Leucovorin + Oxaliplatin (FOLFOX 6, Modified) + Trastuzumab IV BIOSIMILAR Q14D + Pembrolizumab Q42D

Updates

Regimens for the following diagnoses have been updated based on the Collaborative Care Committee voting. Changes include but are not limited to reference update, drug infusion instruction updates, renaming of regimens, premedication template updates and number of cycles.

All Problems
Anemia, Aplastic
Bile Duct Cancer (Parent)
Bladder Cancer
Breast Cancer
Lung Cancer, Non-small Cell (NSCLC)
Lung Cancer, Small Cell (SCLC)

Removals

Lymphoma, Non-Hodgkin (NHL) (Parent)
Multiple Myeloma (MM)
Myelodysplastic Syndrome (MDS)
Paroxysmal Nocturnal Hemoglobinuria
Renal Pelvis and Ureter Cancer
Urethral Cancer
Bortezomib D1,4,8,11,22,25,29,32 + Melphalan PO D1-4 + Prednisone D1-4 (VMP: Initial) Q42D
Bortezomib D1,8,22,29 + Melphalan PO D1-4 + Prednisone D1-4 (VMP: Maintenance) Q42D

Renames

Previous Name	New Name
Antithymocyte globulin D1-4 + Cyclosporine D1- 4 + Prednisone D1-14 Q6M	Antithymocyte globulin D1-4 + Cyclosporine + Prednisone
Nivolumab D1,15,29 + Ipilimumab Q42D (NSCLC)	Nivolumab D1,15,29 + Ipilimumab Q42D (NSCLC, Esophageal)
Paclitaxel D1,8,15 + Carboplatin D1,8,15 Q28D	Paclitaxel D1,8,15 + Carboplatin D1,8,15 Q28D (NSCLC, SCLC, Breast)
Rituximab IV D1,8,15 + DHAP (Cisplatin) Q21D	Rituximab IV + DHAP (Cisplatin) Q21D

Research

Additions

To support Data Migration, applicable clinical trial regimens for US Oncology Research have been migrated and modified for customers migrating from iKnowMed EHR to iKnowMed Generation 2.

Updates

	Updated Reference Information	Updated Drug Service Order Information	Updated Regimen Instructions	Other Changes
USOR 18057	X	X
USOR 18095	X
USOR 18126	X		X
USOR 18194	X	X	X
USOR 19034	X	X	X
USOR 19109	X		X
USOR 20169	X	X		No longer available: USOR 20169 TAK-981 D1,8 + Rituximab IV Q21D USOR 20169 TAK-981 D1,4,8,11 (Dense Schedule) + Rituximab IV Q21D USOR 20169 TAK-981 D1 + Rituximab IV Q21D
USOR 20172	X	X		No longer available: USOR 20172 Cohort K Enfortumab Vedotin D1,8 Q21D USOR 20172 Cohort K Enfortumab Vedotin D1,8 + Pembrolizumab D1 Q21D
USOR 20414	X	X
USOR 20431	X
USOR 21239	X	X	X
USOR 21320	X	X	X
USOR 21326	X	X	X
USOR 21328	X	X	X
USOR 21356	X	X	X
USOR 21377	X	X	X
USOR 21454	X	X	X
USOR 21485	X			Now available: USOR 21485 FT596 D1 USOR 21485 FT596 D1,15 USOR 21485 FT596 D1,4,8 USOR 21485 FT596 D1,8 USOR 21485 FT596 D1,8,15 USOR 21485 Regimen A Conditioning CY/FLU D-5,-4,-3 USOR 21485 Regimen B1 Conditioning CY/FLU D-5,-4,-3 + Rituximab IV BIOSIMILAR D-4 USOR 21485 Regimen B1 Conditioning CY/FLU D-5,-4,-3 + Rituximab IV D-4 USOR 21485 Regimen B2 Conditioning CY/FLU D-5,-4,-3 + Obinutuzumab D-4 USOR 21485 Regimen B3 Conditioning CY/FLU D-5,-4,-3 + Obinutuzumab D-5,-4
USOR 21493		X

Billing: HCPCS Codes

Updates

For a complete list of July 2022 Quarterly Updates, please visit CMS HCPCS.

Medication	HCPCS Code
Bevacizumab-maly IV	J9999 per 100 mg 400 mg
Cabotegravir IM SR Susp	J0739 per 1 mg
COVID-19 Vaccine, mRNA, Pediatric (Moderna) (PF) IM (6 months thru 5 yrs) (Unapproved)	91311 per: 0.25 mL 25 mcg
Efgartigimod alfa-fcab IV	J9332 per 2 mg
Eptifibatide Intracoronary	J1327 per 5 mg
Eptifibatide Intraosseous	J1327 per 5 mg
Immune globulin, Gamma(IgG)-hipp Subcutaneous	J1551 per 100 mg
Inclisiran Subcutaneous	J1306 per 1mg
Kit for Prep of GA 68-Gozetotide IV	A9596 per: 1 mCi 37 MBq
Leuprolide Subcutaneous (6 month) (Camcevi)	J1952 per 1 mg
Plasminogen, Human-txmh IV	J2998 per 1 mg
Ranibizumab Intravitreal (Susvimo)	J2779 per 0.1 mg
Sirolimus-Protein Bound IV	J9331 per 1 mg
Tezepelumab-ekko Subcutaneous	J2356 per 1 mg
Tixagevimab-Cilgavimab Im Dose Pack 150 mg/1.5 mL-150 mg/1.5 mL (EUA)	Q0221 per: 600 mg 2dose pk
Valproic Acid IV	J3490 per 500 mg